PulmonIR is a respiratory healthcare company formed in 2016 and developing a novel respiratory health assessment platform around intellectual property discovered at Swansea University. While the technology has a plethora of applications, the Company will initially focus on delivering a rapid and low-cost system that can be widely deployed in screening patients at high risk of developing lung cancer.

Enquiries relating to PulmonIR should be directed to:

Dr Mark Bowman, CEO
Email: mark.bowman@pulmonir.com
Mobile: +44 (0)7305 219801

respiratory healthcare

Registered company number: 09982535
Registered company address: Institute of Life Science Swansea University, Singleton Park, Swansea, Wales, SA2 8PP